XECAN, a leading innovator in advanced oncology solutions assisted by artificial intelligence, is excited to announce its participation in the upcoming ASTRO 66th Annual Meeting 2024 to showcase its research and innovations to those attending. XECAN will showcase its state of the art AI-assisted products designed to elevate precision, efficiency and improve the overall patient workflow experience.
All visitors are cordially invited to visit our booth and take a look at our presentations. Join our colleagues and staff and learn more about our AI-assisted Clinic Solutions, Radiation Oncology, Chemotherapy, Patient Facial Recognition, Patient accessory verification, and more.
Booth No: 3029
Meeting Dates: September 29 - October 2, 2024
In-Person Location: Walter E. Washington Convention Center, Washington, D.C
Previously, we exhibited our software products at ASTRO’s 2018,2019,2022 and 2023 Annual Meetings.
Our experts will provide immersive demonstrations of our innovative products, seamlessly integrating AI algorithms to optimize patient positioning, facial recognition, and workflow management during radiation treatment. XECAN invites all participants to engage with these cutting-edge technologies and explore how they are reshaping the future of radiation oncology.
For more information about XECAN's participation in ASTRO 2024 and to schedule appointments with their team.
Please get in touch with us:
Email: info@xecan.com
Toll-Free: 1866-469-3226
Int'l: 617-588-0098
Fax: 508-276-0006
About XECAN: XECAN provides AI-assisted clinic solutions to improve clinic workflow, patient tracking, treatment safety and overall quality of patient care. XECAN is a pioneering company developing innovative AI-assisted oncology solutions that empower healthcare providers to deliver precise and personalized radiation therapy. By seamlessly integrating artificial intelligence into its products, XECAN aims to enhance patient outcomes and treatment efficiency, setting new standards in radiation oncology care. Through continuous research and collaboration, XECAN remains dedicated to advancing the field and ensuring patients receive the most effective and compassionate treatment possible.
#xecan #xecanatastro #booth3029 #astro2024